Conjoint Lecturer

Dr amy prawira

medicine-health
St Vincent's Clinical School

Publications

  • Journal articles | 2020
    Dr amy prawira
    Oliva Bernal M; Araujo DV; Chepeha DB; Prawira A; Spreafico A; Bratman SV; Shek T; de Almeida JR; Hansen AR; Hope AJ; Goldstein DP; Weinreb I; Perez-Ordonez B; Pugh TJ; Ohashi PS; Wang BX; Irish JC; Der-Torossian H; Chen I; Siu LL, 2020, 'SNOW: Sitravatinib and nivolumab in oral cavity cancer (OCC) window of opportunity study.', Journal of Clinical Oncology, vol. 38, pp. 6569 - 6569, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.6569
    Journal articles | 2020
    Dr amy prawira
    Prawira A; Coward J; Mislang A; Nagrial A; Gan H; Jin X; Li B; Wang ZM; Kwek KY; Xia D; Xia Y, 2020, '384 A Phase 1 study to evaluate the safety, PK, and antitumor activity of AK117, an anti-CD47 monoclonal antibody, in subjects with relapsed/refractory advanced or metastatic solid tumors or lymphomas', Journal for ImmunoTherapy of Cancer, vol. 8, pp. A409 - A409, http://dx.doi.org/10.1136/jitc-2020-sitc2020.0384
    Journal articles | 2020
    Dr amy prawira
    Millward M; Frentzas S; Gan HK; Prawira A; Tran B; Coward J; Jin X; Li B; Wang M; Kwek KY; Xia Y; Desai J, 2020, '1021O Safety and antitumor activity of AK104, a bispecific antibody targeting PD-1 and CTLA-4, in patients with mesothelioma which is relapsed or refractory to standard therapies', Annals of Oncology, vol. 31, pp. S705 - S706, http://dx.doi.org/10.1016/j.annonc.2020.08.1141
    Journal articles | 2020
    Dr amy prawira
    Gallagher RM; Pattatheyil A; Pantvaidya GH; Panizza BJ; Sharan R; Deshmukh AD; Barnett CME; Swart DJ; Mynott TL; Cleal A; Gordon V; Prawira A, 2020, '974TiP Exploratory phase Ib/IIa study of intratumorally administered tigilanol tiglate to assess safety, tolerability and tumour response in patients with head and neck squamous cell carcinoma', Annals of Oncology, vol. 31, pp. S684 - S684, http://dx.doi.org/10.1016/j.annonc.2020.08.1089
    Journal articles | 2020
    Dr amy prawira
    Mislang ARA; Coward J; Cooper A; Underhill CR; Zheng Y; Xu N; Xiao C; Jin X; Li B; Wang M; Kwek KY; Xia D; Xia Y; Prawira A, 2020, '157P Efficacy and safety of penpulimab (AK105), a new generation anti-programmed cell death-1 (PD-1) antibody, in upper gastrointestinal cancers', Annals of Oncology, vol. 31, pp. S1300 - S1301, http://dx.doi.org/10.1016/j.annonc.2020.10.178
    Journal articles | 2020
    Dr amy prawira
    Joshua AM; Prawira A; Thavaneswaran S; Cosman R; Lee CK; Sjoquist KM; Simes J; Thomas DM; Espinoza D; Sebastian L; Ballinger ML; Hague W; Chinchen S; Collignon E; Kansara M; Palacios T; Grady J; Barker H; Thornton K, 2020, 'A signal-seeking trial of olaparib and durvalumab in homologous repair-deficient tumors: A sub-study of the cancer molecular screening and therapeutics (MoST) program.', Journal of Clinical Oncology, vol. 38, pp. 3073 - 3073, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.3073
    Journal articles | 2019
    Dr amy prawira
    Stradella A; Johnson ML; Goel S; Chandana SR; Galsky MD; Calvo E; Moreno V; Park H; Arkenau H-T; Cervantes A; Madrid LF; Mileshkin L; Plummer R; Evans J; Horvath L; Prawira A; Pelham RJ; Mu S; Andreu-Vieyra C; Barve M, 2019, 'Updated results of the PARP1/2 inhibitor pamiparib in combination with low-dose (ld) temozolomide (TMZ) in patients (pts) with locally advanced or metastatic solid tumours', Annals of Oncology, vol. 30, pp. v166 - v167, http://dx.doi.org/10.1093/annonc/mdz244.013
    Journal articles | 2019
    Dr amy prawira
    Hansen AR; Tannock IF; Templeton A; Chen E; Evans A; Knox J; Prawira A; Sridhar SS; Tan S; Vera-Badillo F; Wang L; Wouters BG; Joshua AM, 2019, 'Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC)', Oncologist, vol. 24, pp. 1188 - 1194, http://dx.doi.org/10.1634/theoncologist.2018-0621
    Journal articles | 2019
    Dr amy prawira
    Mehnert JM; Varga A; Brose MS; Aggarwal RR; Lin CC; Prawira A; De Braud F; Tamura K; Doi T; Piha-Paul SA; Gilbert J; Saraf S; Thanigaimani P; Cheng JD; Keam B, 2019, 'Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer', BMC Cancer, vol. 19, http://dx.doi.org/10.1186/s12885-019-5380-3
    Journal articles | 2018
    Dr amy prawira
    Hong DS; Schoffski P; Calvo A; Sarantopoulos J; Ochoa De Olza M; Carvajal RD; Prawira A; Kyi C; Esaki T; Akerley WL; De Braud FG; Hui R; Zhang T; Soo RA; Maur M; Weickhardt AJ; Roy Chowdhury N; Sabatos-Peyton C; Kwak EL; Tan DS-W, 2018, 'Phase I/II study of LAG525 ± spartalizumab (PDR001) in patients (pts) with advanced malignancies.', Journal of Clinical Oncology, vol. 36, pp. 3012 - 3012, http://dx.doi.org/10.1200/jco.2018.36.15_suppl.3012
    Journal articles | 2017
    Dr amy prawira
    George M; Mandaliya H; prawira A, 2017, 'A survey of medical oncology training in Australian Medical Schools: pilot study', JMIR Medical Education, vol. 12, pp. e23 - e23, http://dx.doi.org/10.2196/mededu.7903
    Journal articles | 2017
    Dr amy prawira
    Prawira A; Pugh TJ; Stockley TL; Siu LL, 2017, 'Data resources for the identification and interpretation of actionable mutations by clinicians', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 28, pp. 946 - 957, http://dx.doi.org/10.1093/annonc/mdx023
    Journal articles | 2017
    Dr amy prawira
    Prawira A; Oosting SF; Chen TW; Delos Santos KA; Saluja R; Wang L; Siu LL; Chan KKW; Hansen AR, 2017, 'Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review', British Journal of Cancer, vol. 117, pp. 1743 - 1752, http://dx.doi.org/10.1038/bjc.2017.357
    Journal articles | 2017
    Dr amy prawira
    Infante JR; Bedard PL; Shapiro G; Bauer TM; Prawira A; Laskin O; Weetall M; Baird J; Branstrom A; O'Mara E; Spiegel RJ, 2017, 'Phase 1 results of PTC596, a novel small molecule targeting cancer stem cells (CSCs) by reducing levels of BMI1 protein.', Journal of Clinical Oncology, vol. 35, pp. 2574 - 2574, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.2574
    Journal articles | 2017
    Dr amy prawira
    Prawira A; Lazinski D; Siu LL; Perez-Ordonez B, 2017, 'Giant Prolactinoma Presenting As a Base of Skull Tumor With Nasopharyngeal Extension: A Potential Diagnostic Pitfall in Neuroendocrine Lesions of the Base of Skull', Head and Neck Pathology, vol. 11, pp. 537 - 540, http://dx.doi.org/10.1007/s12105-017-0782-5
    Journal articles | 2017
    Dr amy prawira
    Prawira A; Stundzia AB; Dufort P; Halankar J; Paravasthu DM; Spreafico A; Hansen AR; Abdul Razak AR; Bedard PL; Butler M; Lheureux S; Oza AM; Jang RW; Suta KM; Boross-Harmer S; Cipollone J; Chow H; Metser U; Siu LL, 2017, 'Evaluation of a predictive radiomics signature for response to immune checkpoint inhibitors (ICIs)', Annals of Oncology, vol. 28, pp. v31 - v31, http://dx.doi.org/10.1093/annonc/mdx363.031
    Journal articles | 2017
    Dr amy prawira
    Wong H-L; Luechtefeld T; Prawira A; Patterson Z; Workman J; Day D; Chooback N; Nappi L; Samawi HH; Lavoie J-M; Spreafico A; Hansen AR; Sahebjam S; Siu LL; Ivy SP; Paller C; Renouf D, 2017, 'Development of a web-based application using machine learning algorithms to facilitate systematic literature reviews', Annals of Oncology, vol. 28, pp. v518 - v518, http://dx.doi.org/10.1093/annonc/mdx385.023
    Journal articles | 2016
    Dr amy prawira
    Prawira A; Oosting S; Chen TW-W; Saluja R; Delos Santos K; Wang L; Siu LL; Chan KK; Hansen AR, 2016, 'Systemic therapies for recurrent/metastatic nasopharyngeal carcinoma (RM NPC).', Journal of Clinical Oncology, vol. 34, pp. 6031 - 6031, http://dx.doi.org/10.1200/jco.2016.34.15_suppl.6031
    Journal articles | 2016
    Dr amy prawira
    Mehnert JM; Varga A; Brose M; Aggarwal RR; Lin C-C; Prawira A; de Braud F; Tamura K; Doi T; Piha-Paul SA; Gilbert J; Saraf S; Thanigaimani P; Cheng JD; Keam B, 2016, 'Pembrolizumab for advanced papillary or follicular thyroid cancer: preliminary results from the phase 1b KEYNOTE-028 study.', Journal of Clinical Oncology, vol. 34, pp. 6091 - 6091, http://dx.doi.org/10.1200/jco.2016.34.15_suppl.6091
    Journal articles | 2016
    Dr amy prawira
    Shapiro G; Bedard P; Infante J; Bauer T; Prawira A; Laksin O; Weetall M; Baird J; Branstrom A; O'Mara E; Spiegel R, 2016, 'Phase 1 results of PTC596, a novel small molecule targeting cancer stem cells (CSCs) by reducing levels of BMI1 protein', European Journal of Cancer, vol. 69, pp. S148 - S148, http://dx.doi.org/10.1016/s0959-8049(16)33039-8
    Journal articles | 2016
    Dr amy prawira
    Prawira A; Dufort P; Halankar J; Paravasthu DM; Hansen A; Spreafico A; Razak ARA; Chen E; Jang RW; Metser U; Siu LL, 2016, 'Development of a predictive radiomics signature for response to immune checkpoint inhibitors (ICIs) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN)', Annals of Oncology, vol. 27, pp. vi330, http://dx.doi.org/10.1093/annonc/mdw376.08
    Journal articles | 2016
    Dr amy prawira
    Shapiro G; Infante J; Bauer TM; Prawira A; Bedard P; Laskin O; Weetall M; Baird J; O'Mara E; Spiegel R, 2016, 'Initial first-in-human phase 1 results of PTC596, a novel small molecule that targets cancer stem cells (CSCs) by reducing BMI1 protein levels', Annals of Oncology, vol. 27, pp. vi122, http://dx.doi.org/10.1093/annonc/mdw368.27
    Journal articles | 2016
    Dr amy prawira
    Prawira A; Brana-Garcia I; Spreafico A; Hope A; Waldron J; Razak ARA; Chen EX; Jang R; O’Sullivan B; Giuliani M; Bayley A; Cho J; Wang L; Perez-Ordonez B; Weinreb I; Siu LL; Hansen AR, 2016, 'Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001)', Investigational New Drugs, vol. 34, pp. 575 - 583, http://dx.doi.org/10.1007/s10637-016-0367-2
    Journal articles | 2015
    Dr amy prawira
    Mandaliya H; Baghi P; Prawira A; George MK, 2015, 'A Rare Case of Paclitaxel and/or Trastuzumab Induced Acute Hepatic Necrosis.', Case Rep Oncol Med, vol. 2015, pp. 825603, http://dx.doi.org/10.1155/2015/825603
    Journal articles | 2014
    Dr amy prawira
    George M; Ngo P; Prawira A, 2014, 'Rural oncology: Overcoming the tyranny of distance for improved cancer care', Journal of Oncology Practice, vol. 10, pp. e146 - e149, http://dx.doi.org/10.1200/JOP.2013.001228
    Journal articles | 2009
    Dr amy prawira
    Wong MLH; Prawira A; Kaye AH; Hovens CM, 2009, 'Tumour angiogenesis: Its mechanism and therapeutic implications in malignant gliomas', Journal of Clinical Neuroscience, vol. 16, pp. 1119 - 1130, http://dx.doi.org/10.1016/j.jocn.2009.02.009
  • Conference Abstracts | 2020
    Dr amy prawira
    Stradella A; Johnson M; Goel S; Chandana SR; Galsky MD; Calvo E; Moreno V; Park H; Arkenau T; Cervantes A; Farinas-Madrid L; Mileshkin L; Fu S; Plummer R; Evans J; Horvath L; Prawira A; Qu K; Pelham R; Barve MA, 2020, 'Clinical benefit in biomarker-positive patients (pts) with locally advanced or metastatic solid tumours treated with the PARP1/2 inhibitor pamiparib in combination with low-dose (LD) temozolomide (TMZ)', in ANNALS OF ONCOLOGY, ELSEVIER, ELECTR NETWORK, Vol. 31, pp. S465 - S466, presented at ESMO Virtual Congress, ELECTR NETWORK, 19 September 2020 - 18 October 2020, http://dx.doi.org/10.1016/j.annonc.2020.08.644
    Conference Abstracts | 2020
    Dr amy prawira
    Markman B; Day D; Park JJW; Coward J; Bishnoi S; Kotasek D; Eek R; Brown MP; Lemech C; Kuo J; Prawira A; Strother R; Zhang Q; Wang L; Chen R; Ma Y; Qin Z; Tse A, 2020, 'Preliminary pharmacokinetics (PK), safety and efficacy of two dosing regimens of CS1003 (anti-PD-1) in solid tumours: 200 mg every 3-week (Q3W) and 400 mg every 6-week (Q6W) dosing', in ANNALS OF ONCOLOGY, ELSEVIER, ELECTR NETWORK, Vol. 31, pp. S722 - S722, presented at ESMO Virtual Congress, ELECTR NETWORK, 19 September 2020 - 18 October 2020, http://dx.doi.org/10.1016/j.annonc.2020.08.1177
    Conference Papers | 2019
    Dr amy prawira
    Bernal MO; Chepeha D; Prawira A; Vines D; Spreafico A; Bratman S; Almeida JD; Hansen A; Goldstein D; Gilbert R; Gullane P; Brown DH; Weinreb I; Perez-Ordoñez B; Ohashi PS; McGaha T; Wang BX; Irish J; Chen I; Siu LL, 2019, 'Abstract CT124: Sitravatinib and nivolumab in oral cavity cancer window of opportunity study (SNOW)', in Clinical Trials, American Association for Cancer Research, presented at Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA, http://dx.doi.org/10.1158/1538-7445.sabcs18-ct124
    Conference Papers | 2019
    Dr amy prawira
    Bernal MO; Chepeha D; Prawira A; Vines D; Spreafico A; Bratman S; Almeida JD; Hansen A; Goldstein D; Gilbert R; Gullane P; Brown DH; Weinreb I; Perez-Ordoñez B; Ohashi PS; McGaha T; Wang BX; Irish J; Chen I; Siu LL, 2019, 'Abstract CT124: Sitravatinib and nivolumab in oral cavity cancer window of opportunity study (SNOW)', in Clinical Trials, American Association for Cancer Research, presented at Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA, http://dx.doi.org/10.1158/1538-7445.am2019-ct124
    Conference Papers | 2019
    Dr amy prawira
    Kotasek D; Coward J; de Souza PL; Underhill C; Jin X; Li B; Xia Y; Prawira A, 2019, 'A phase I dose escalation and dose expansion study of the anti-programmed cell death-1 (PD-1) antibody AK105.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 31 May 2019 - 04 June 2019, http://dx.doi.org/10.1200/JCO.2019.37.15_suppl.e14006
    Conference Abstracts | 2019
    Dr amy prawira
    Millward M; Gan HK; Joshua AM; Kuo JC-Y; Prawira A; Richardson GE; Barbee SD; Inamdar SP; Pierce KL; Qureshi M; Horvath L, 2019, 'FPT155-001: A phase Ia/Ib study of FPT155 (CD80-FC) in patients with advanced solid tumors.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, Vol. 37, presented at ASCO-SITC Clinical Immuno-Oncology Symposium, San Francisco, CA, 28 February 2019 - 02 March 2019, http://dx.doi.org/10.1200/JCO.2019.37.8_suppl.TPS42
    Conference Papers | 2018
    Dr amy prawira
    Xu K; Lo A; Chin V; Gzell C; O'Connor C; Forstner D; Gallagher R; Bova R; Crawford J; Harvey R; Lochhead A; Earls P; Qiu MR; Hsu E; Bigg-Wither G; Chan L; Bao H; Foltyn P; Sim HW; Prawira A, 2018, 'Development of overall survival (OS) and progression free survival (PFS) nomograms for Australian patients with locoregionally advanced oropharyngeal squamous cell carcinoma (LA OPSCC)', in Annals of oncology : official journal of the European Society for Medical Oncology, OXFORD UNIV PRESS, Munich, GERMANY, pp. viii389, presented at 43rd ESMO Congress (ESMO), Munich, GERMANY, 19 October 2018 - 23 October 2018, http://dx.doi.org/10.1093/annonc/mdy287.049
    Conference Posters | 2016
    Dr amy prawira
    Hansen AR; Tannock I; Prawira A; Knox JJ; Templeton AJ; Vera-Badillo F; Chen EX; Zavitz M-B; Wang L; Evans A; Tan S; Wouters B; Sridhar SS; Joshua AM, 2016, 'Pantoprazole affecting docetaxel resistance pathways via autophagy (PANDORA): a phase II trial in men with castration resistant prostate cancer (mCRPC).', Chicago, IL, Vol. 34, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 03 June 2016 - 07 June 2016, http://dx.doi.org/10.1200/JCO.2016.34.15_suppl.e16502
    Conference Posters | 2016
    Dr amy prawira
    Hansen A; Tannock I; Templeton AJ; Prawira A; Knox J; Vera-Badillo F; Chen E; Zavitz MB; Wang L; Evans A; Tan Q; Wouters B; Sridhar S; Joshua A, 2016, 'Pantoprazole affecting docetaxel resistance pathways via autophagy (PANDORA): A phase II trial in men with metastatic castrate resistant prostate cancer (mCRPC)', Copenhagen, DENMARK, Vol. 27, pp. vi249, presented at 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, DENMARK, 07 October 2016 - 11 October 2016, http://dx.doi.org/10.1093/annonc/mdw372.20

Awards

Grants

Media